{"schema_version":"secwatch.filing_event.v1","accession":"0001846253-25-000022","form_type":"8-K","ticker":"OABI","cik":"0001846253","company_name":"OmniAb, Inc.","filed_at":"2025-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.259083+00:00","generated_at":"2026-05-24T14:31:46.594146+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"OmniAb Q4 rev $10.8M, net loss $13.1M; guides FY25 rev $20-25M, opex $90-95M","bullets":["Q4 revenue $10.8M (up from $4.8M YoY); net loss $13.1M ($0.12/shr) vs $14.1M loss prior year.","FY2024 revenue $26.4M (down from $34.2M); net loss $62.0M ($0.61/shr) vs $50.6M loss in 2023.","Cash and investments $59.4M at Dec 31, 2024; expects 2025 cash use below 2024's $38.9M.","2025 guidance: revenue $20-25M, operating expense $90-95M, effective tax rate ~0%.","91 active partners, 363 active programs; 10 new license agreements in 2024 (incl. Incyte, Photinia)."],"urls":{"canonical":"https://secwatch.observer/filing/0001846253-25-000022","json":"https://secwatch.observer/filing/0001846253-25-000022.json","markdown":"https://secwatch.observer/filing/0001846253-25-000022.md","text":"https://secwatch.observer/filing/0001846253-25-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000022/0001846253-25-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000022/oabi-20250318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T14:31:46.594146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}